Optus Pharmaceutical
옵투스제약 · 131030
Health Care Pharmaceuticals · KOSDAQ
Market cap US$77.9M (₩107.5B)
Overview
Optus Pharmaceutical makes prescription and over-the-counter eye drops, including preservative-free single-use vials, used to treat dry eye, glaucoma, and allergic conditions.
Listed on KOSDAQ, Korea's tech and small-cap board, it supplies hospitals and clinics directly and also manufactures eye drops on behalf of other pharmaceutical companies under contract development and manufacturing arrangements. Its business spans four segments: a prescription ophthalmology unit, a contract manufacturing unit, an export-focused global unit, and a consumer eye-care brand called OUE&.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$52.5M
- FY2024US$59.4M
- FY2025US$63.2M
Operating profit
- FY2023US$5.9M
- FY2024US$6.2M
- FY2025US$6.4M
Net income
- FY2023US$7.8M
- FY2024US$7.5M
- FY2025US$8.2M
Key ratios (FY2025)
Why it matters
The company operates its own production facility in the Osong Life Science Industrial Complex in Chungcheongbuk-do and a central research institute in Suwon, giving it in-house manufacturing and R&D capabilities.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?